Search

Your search keyword '"Aroldi, A"' showing total 1,232 results

Search Constraints

Start Over You searched for: Author "Aroldi, A" Remove constraint Author: "Aroldi, A"
1,232 results on '"Aroldi, A"'

Search Results

2. Idiopathic erythrocytosis: a germline disease?

3. A phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)

4. First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

6. ICTs in Later Life and Post-pandemic Challenges

7. Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients

10. First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

11. Idiopathic erythrocytosis: a germline disease?

12. Lag3: From Bench to Bedside

13. Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID‐19 vaccine: A single‐center prospective observational study (NCT05074706)

15. Being social

21. Media, Generations, and the Platform Society

22. Lag3: From Bench to Bedside

23. Integrative multi-omics analysis enables a comprehensive characterization of prostate cancer and unveils metastasis-associated candidate biomarkers

27. Infanzia, adolescenza e culture dei media

28. Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making

29. A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas

30. ICTs in Later Life and Post-pandemic Challenges.

31. Premessa al volume

32. Balancing Cultural and Economic Value: The Italian Way to Children’s Television (1954– 2021)

33. Being Social

34. Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples

35. From 'Listen' to 'Speak'. A range of possible social media activities between private and public in a cross-regional perspective

37. 506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 ± nivolumab in patients with advanced solid tumors

38. 507 A phase 1 clinical trial of RP2, an enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody, as a single agent and combined with nivolumab in patients with advanced solid tumors

39. Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples

40. Evaluating the performance of large language models in haematopoietic stem cell transplantation decision‐making.

41. Evaluating the performance of large language models in haematopoietic stem cell transplantation decision‐making

42. A Phase I open-label, dose-escalation study of NUC-3373, a targeted thymidylate synthase inhibitor, in patients with advanced cancer (NuTide:301)

44. Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

48. A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas

50. Exploring digital disconnection. Una proposta di rilettura del dibattito internazionale sulla disconnessione digitale

Catalog

Books, media, physical & digital resources